Platelet-Rich Plasma, Hyaluronic Acid Improves Aging Facial Skin

This article originally appeared here.
Share this content:
Platelet-Rich Plasma, Hyaluronic Acid Improves Aging Facial Skin
Platelet-Rich Plasma, Hyaluronic Acid Improves Aging Facial Skin

MONDAY, Sept. 12, 2016 (HealthDay News) -- Injection of platelet-rich plasma (PRP) and hyaluronic acid (HA) is associated with a clinically visible and statistically significant improvement in aging facial skin, according to a study published online Sept. 5 in the Journal of Cosmetic Dermatology.

Betul Gozel Ulusal, M.D., from Balikesir University in Turkey, treated 94 female patients with varying degrees of facial aging signs to treatment with PRP and HA. Patients rated their personal satisfaction with skin texture, pigmentation, and sagging. Three independent physicians and the patients themselves also rated the overall results. The association between the degree of esthetic scores and number of injections was examined.

Ulusal found that according to the patients, there was a significant difference in general appearance, skin firmness-sagging, and skin texture before and after application of PRP. The number of injections was significantly correlated with overall satisfaction.

"Compared to the baseline, the PRP and HA injections provided clinically visible and statistically significant improvement on facial skin," Ulusal writes. "The improvements were more remarkable as the injection numbers increased."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »